We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OTSUKA AUTHORIZED DEAL AVOIDS PEER COMPETITION
OTSUKA AUTHORIZED DEAL AVOIDS PEER COMPETITION
November 2, 2004
Brand firm Otsuka America Pharmaceutical has signed an agreement allowing specialty pharma company Prasco Laboratories to launch an authorized generic version of its leg-pain drug Pletal — a launch that precedes outside generic competition on the product.